Quarterly report pursuant to Section 13 or 15(d)

Restatement of Condensed Consolidated Financial Statements (Details)

v3.22.1
Restatement of Condensed Consolidated Financial Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jun. 30, 2021
Jun. 30, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Net revenues [1] $ 158,075 $ 59,012
License fees and revenue share [1] 83,808 32,300
Other direct costs of revenues [1] 4,468 560
Product development [1] 12,924 4,408
Sales and marketing [1] 13,736 4,318
General and administrative [1] 23,984 6,804
Restructuring and impairment costs [1] 10 0
Total costs of revenues and operating expenses [1] 138,930 48,390
Income from operations [1] 19,145 $ 10,622
Reported    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Net revenues 212,615  
License fees and revenue share 138,348  
Other direct costs of revenues 2,533  
Product development 15,547  
Sales and marketing 13,736  
General and administrative 23,296  
Restructuring and impairment costs 10  
Total costs of revenues and operating expenses 193,470  
Income from operations 19,145  
Adjustment    
New Accounting Pronouncements or Change in Accounting Principle [Line Items]    
Net revenues (54,540)  
License fees and revenue share (54,540)  
Other direct costs of revenues 1,935  
Product development (2,623)  
Sales and marketing 0  
General and administrative 688  
Restructuring and impairment costs $ 0  
[1] In the quarter ending June 30, 2021, the Company initiated two significant acquisitions. Please refer to Note 4 in the accompanying condensed consolidated financial statements.